WO2014093127A3 - Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit - Google Patents

Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit Download PDF

Info

Publication number
WO2014093127A3
WO2014093127A3 PCT/US2013/073346 US2013073346W WO2014093127A3 WO 2014093127 A3 WO2014093127 A3 WO 2014093127A3 US 2013073346 W US2013073346 W US 2013073346W WO 2014093127 A3 WO2014093127 A3 WO 2014093127A3
Authority
WO
WIPO (PCT)
Prior art keywords
conditioning unit
cannabidiol
thc
tobacco
agent
Prior art date
Application number
PCT/US2013/073346
Other languages
French (fr)
Other versions
WO2014093127A2 (en
WO2014093127A4 (en
Inventor
Richard C. Fuisz
Joseph M. Fuisz
Original Assignee
Fuisz Richard C
Fuisz Joseph M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/715,028 external-priority patent/US20140166027A1/en
Application filed by Fuisz Richard C, Fuisz Joseph M filed Critical Fuisz Richard C
Publication of WO2014093127A2 publication Critical patent/WO2014093127A2/en
Publication of WO2014093127A3 publication Critical patent/WO2014093127A3/en
Publication of WO2014093127A4 publication Critical patent/WO2014093127A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D1/00—Cigars; Cigarettes
    • A24D1/002—Cigars; Cigarettes with additives, e.g. for flavouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)

Abstract

A method for the administration of nicotine, THC, tobacco, cannabidiol or a base alkaloid includes administering in the oral or nasal cavity an absorption conditioning unit having at least two agents selected from the group consisting of (a) a buffer agent, (b) a capturing agent, (c) a penetration agent, and (d) a thermal agent, to the mammal, and then administering by inhalation a bioactive agent selected from the group consisting of nicotine, THC, cannabidiol and a base alkaloid. The absorption conditioning unit may be in a dosage form not containing a drug. The absorption conditioning unit may create a pH in the oral cavity or nasal cavity of 7.8-10 for a period of ten minutes or more after administration, the dosage form not containing an acid and not containing a drug.
PCT/US2013/073346 2012-12-14 2013-12-05 Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit WO2014093127A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13/715,028 US20140166027A1 (en) 2012-12-14 2012-12-14 Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
US13/715,028 2012-12-14
US13/871,213 2013-04-26
US13/871,213 US20140166028A1 (en) 2012-12-14 2013-04-26 Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit

Publications (3)

Publication Number Publication Date
WO2014093127A2 WO2014093127A2 (en) 2014-06-19
WO2014093127A3 true WO2014093127A3 (en) 2014-10-16
WO2014093127A4 WO2014093127A4 (en) 2014-11-27

Family

ID=50929509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/073346 WO2014093127A2 (en) 2012-12-14 2013-12-05 Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit

Country Status (2)

Country Link
US (1) US20140166028A1 (en)
WO (1) WO2014093127A2 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US9259035B2 (en) 2010-05-15 2016-02-16 R. J. Reynolds Tobacco Company Solderless personal vaporizing inhaler
US9861772B2 (en) 2010-05-15 2018-01-09 Rai Strategic Holdings, Inc. Personal vaporizing inhaler cartridge
US9743691B2 (en) 2010-05-15 2017-08-29 Rai Strategic Holdings, Inc. Vaporizer configuration, control, and reporting
US9095175B2 (en) 2010-05-15 2015-08-04 R. J. Reynolds Tobacco Company Data logging personal vaporizing inhaler
US10136672B2 (en) 2010-05-15 2018-11-27 Rai Strategic Holdings, Inc. Solderless directly written heating elements
US8757147B2 (en) 2010-05-15 2014-06-24 Minusa Holdings Llc Personal vaporizing inhaler with internal light source
US9999250B2 (en) 2010-05-15 2018-06-19 Rai Strategic Holdings, Inc. Vaporizer related systems, methods, and apparatus
US10159278B2 (en) 2010-05-15 2018-12-25 Rai Strategic Holdings, Inc. Assembly directed airflow
US11344683B2 (en) * 2010-05-15 2022-05-31 Rai Strategic Holdings, Inc. Vaporizer related systems, methods, and apparatus
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
US10639439B2 (en) 2013-01-30 2020-05-05 Midwest Pharmaceuticals, Llc Smokeless THC and administration method thereof
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
IL297399B2 (en) 2013-05-06 2024-02-01 Juul Labs Inc Nicotine salt formulations for aerosol devices and methods thereof
WO2014201432A1 (en) 2013-06-14 2014-12-18 Ploom, Inc. Multiple heating elements with separate vaporizable materials in an electric vaporization device
US10980273B2 (en) 2013-11-12 2021-04-20 VMR Products, LLC Vaporizer, charger and methods of use
CN113142679A (en) 2013-12-05 2021-07-23 尤尔实验室有限公司 Nicotine liquid formulations for aerosol devices and methods thereof
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US9549573B2 (en) 2013-12-23 2017-01-24 Pax Labs, Inc. Vaporization device systems and methods
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
CA3132323C (en) 2013-12-23 2023-02-07 Juul Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US9820510B2 (en) 2014-01-03 2017-11-21 Robert P Thomas, Jr. Vapor delivery device
US10117463B2 (en) 2014-01-03 2018-11-06 Robert P Thomas, Jr. Vapor delivery device
CA2948851A1 (en) 2014-05-16 2015-11-19 Pax Labs, Inc. Systems and methods for aerosolizing a smokeable material
EP3168605B1 (en) * 2014-07-08 2020-03-04 China National Tobacco Quality Supervision&test Center Buffer system and method of using the buffer system to measure total alkaloid in tobacco or tobacco products through continuous flow
WO2016019353A1 (en) * 2014-07-31 2016-02-04 MJAR Holdings, LLC Electronic cigarettes, cartridges, and inhalable formulations of medicinal cannabis compounds, and apparatuses and methods for making and using the same
ES2948035T3 (en) * 2014-10-03 2023-08-30 Fertin Pharma As Electronic Nicotine Delivery System
CN112155255A (en) 2014-12-05 2021-01-01 尤尔实验室有限公司 Corrective dose control
US10172786B2 (en) * 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
WO2016171997A2 (en) * 2015-04-21 2016-10-27 Viriyapanthu Paul Composition of smokeless tobacco, method and apparatus for vaporization
CN111990695A (en) 2015-05-06 2020-11-27 奥驰亚客户服务有限责任公司 Non-combustion smoking device and components thereof
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
EP3162229B1 (en) 2015-10-28 2022-03-30 Fontem Holdings 1 B.V. Electronic smoking device with a variable-volume liquid reservoir
WO2017139675A1 (en) 2016-02-11 2017-08-17 Pax Labs, Inc. Securely attaching cartridges for vaporizer devices
UA125687C2 (en) 2016-02-11 2022-05-18 Джуул Лебз, Інк. Fillable vaporizer cartridge and method of filling
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
CN109310962A (en) 2016-04-11 2019-02-05 阿勒托帕股份有限公司 Safe, portable, on-demand Microfluidic Mixing and distributor
US9901607B2 (en) 2016-04-28 2018-02-27 Mark J. Silen Smokeless cannabis composition and method of manufacture
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
US10709165B2 (en) * 2016-09-27 2020-07-14 Bond Street Manufacturing Llc Vaporizable tobacco wax compositions
US10842193B2 (en) 2016-10-04 2020-11-24 Altria Client Services Llc Non-combustible smoking device and elements thereof
WO2018069938A1 (en) * 2016-10-14 2018-04-19 Cipla Limited Pharmaceutical compositions comprising rifaximin
US10188628B1 (en) 2016-10-27 2019-01-29 Alvin Kershman Release composition for derivatives of Cannabaceae
EP3488220A4 (en) * 2016-11-29 2020-03-04 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
US10433585B2 (en) 2016-12-28 2019-10-08 Altria Client Services Llc Non-combustible smoking systems, devices and elements thereof
USD802992S1 (en) 2017-01-16 2017-11-21 Altopa, Inc. Blend machine
NL2018504B1 (en) * 2017-03-13 2018-09-21 Pharma Unlimited B V Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction
EP3629776B1 (en) * 2017-05-24 2021-02-17 Philip Morris Products S.a.s. Homogenised botanical material comprising a basic ph modifier
USD873068S1 (en) 2017-07-16 2020-01-21 Altopa, Inc. Blend device
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
US20210220371A1 (en) * 2017-09-20 2021-07-22 Calista Capital, Llc Method for smoking cessation
US10966988B2 (en) 2017-09-20 2021-04-06 Calista Capital, Llc Method for smoking cessation
US11083765B2 (en) * 2017-12-15 2021-08-10 Andrew Scott Davis Hemp leaf chew composition and method for producing
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US11116720B2 (en) * 2018-08-29 2021-09-14 Nanthealth, Inc. Ice pop medicament delivery system and method
EP3876759A1 (en) 2018-11-05 2021-09-15 Juul Labs, Inc. Cartridges for vaporizer devices
WO2020112063A1 (en) * 2018-11-29 2020-06-04 Yildiz Teknik Universitesi A nasal solution with closed basin natural spring water characteristic and method for obtaining said nasal solution
EP3923750A1 (en) 2019-02-11 2021-12-22 SWM Luxembourg Cannabis wrapper for smoking articles
US11723398B2 (en) 2019-02-11 2023-08-15 Mativ Holdings, Inc. Cocoa wrapper for smoking articles
US11957160B2 (en) 2019-02-11 2024-04-16 Mativ Holdings, Inc. Filler containing blends of aerosol generating materials
KR20210125563A (en) 2019-02-11 2021-10-18 에스더블유엠 룩셈부르크 Reconstituted cocoa material for aerosol generation
KR20210127730A (en) 2019-02-11 2021-10-22 에스더블유엠 룩셈부르크 Reconstituted Cannabis Ingredients for Aerosol Generation
JP2022533837A (en) * 2019-05-20 2022-07-26 ポビバ コーポレーション Compositions containing bioactive substances and bile salts
IL273561B (en) * 2020-03-24 2022-03-01 Roxx Labs Ltd Cannabinoid compositions and aerosols
US20230329317A1 (en) * 2021-03-30 2023-10-19 Open Book Extracts Enhanced Herbal Smoking Blend
CN114903889B (en) * 2022-05-17 2023-02-03 暨南大学 Lizatriptan nasal spray and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
US20060198873A1 (en) * 2003-07-24 2006-09-07 Chan Shing Y Orally dissolving films
US20090023819A1 (en) * 2005-03-22 2009-01-22 Anders Axelsson Use of an Artificial Sweetener to Enhance Absorption of Nicotine
US20100242978A1 (en) * 2007-10-11 2010-09-30 Fuisz Richard C Smokeless tobacco product
US20110293535A1 (en) * 2009-02-11 2011-12-01 Heglund, A.S. Composition for buccal absorption of nicotine for the purpose of smoking cessation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130156871A1 (en) * 2011-12-20 2013-06-20 Water Pik, Inc. Nasal Wash Solution

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
US20060198873A1 (en) * 2003-07-24 2006-09-07 Chan Shing Y Orally dissolving films
US20090023819A1 (en) * 2005-03-22 2009-01-22 Anders Axelsson Use of an Artificial Sweetener to Enhance Absorption of Nicotine
US20100242978A1 (en) * 2007-10-11 2010-09-30 Fuisz Richard C Smokeless tobacco product
US20110293535A1 (en) * 2009-02-11 2011-12-01 Heglund, A.S. Composition for buccal absorption of nicotine for the purpose of smoking cessation

Also Published As

Publication number Publication date
WO2014093127A2 (en) 2014-06-19
US20140166028A1 (en) 2014-06-19
WO2014093127A4 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
WO2014093127A3 (en) Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
WO2006086107A3 (en) Methods and compositions for minimizing accrual of inhalable insulin in the lungs
MX2009012485A (en) Oral nicotine formulation buffered with amino acid.
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
WO2009008001A3 (en) Inhalation device
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
CL2014001437A1 (en) Compounds derived from aryl dihydropyridinone and piperidinone as inhibitors of monoacrylic glycerol acyltransferase (mgat2); pharmaceutical composition and combination; and use in the treatment and prevention of diabetes, hyperglycemia, retinopathy, metabolic syndrome, among other diseases.
IL198314A (en) Quinuclidine derivatives of (hetero) arylcycloheptanecarboxylic acid, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for therapy
MX2022009231A (en) Dry powder inhaler and methods of use.
BRPI0806392A8 (en) use of aclidinium, aclidinium, treatment or prevention method and pharmaceutical composition
EA032951B1 (en) Glutarimide derivative, use thereof, pharmaceutical composition based thereon, process for preparing same
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
WO2010090494A3 (en) Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
JP2018527386A5 (en)
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
PH12016500142A1 (en) Vesicles
EA201591415A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING MULTICOMPONENT CRYSTALLINE PARTICLES, SUITABLE FOR USE IN INHALATION THERAPY
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
WO2012145555A3 (en) Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
RU2011136100A (en) PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PRODUCTION AND DEVICE FOR ITS APPLICATION
PH12014501822A1 (en) Oral formulation comprising lansoprazole and the preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13862265

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13862265

Country of ref document: EP

Kind code of ref document: A2